|
| Entrez Id: |
59340 |
| Gene Symbol: |
HRH4 |
HRH4
|
0.300 |
Biomarker
|
disease |
CTD_human |
Deletion and down-regulation of HRH4 gene in gastric carcinomas: a potential correlation with tumor progression.
|
22363581 |
2012 |
|
| Entrez Id: |
4354 |
| Gene Symbol: |
MPP1 |
MPP1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis.
|
21552421 |
2011 |
|
| Entrez Id: |
6934 |
| Gene Symbol: |
TCF7L2 |
TCF7L2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.
|
21892161 |
2011 |
|
| Entrez Id: |
8856 |
| Gene Symbol: |
NR1I2 |
NR1I2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett's esophagus and esophageal adenocarcinoma.
|
21977915 |
2011 |
|
| Entrez Id: |
6776 |
| Gene Symbol: |
STAT5A |
STAT5A
|
0.300 |
Biomarker
|
disease |
CTD_human |
Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis.
|
21552421 |
2011 |
|
| Entrez Id: |
6599 |
| Gene Symbol: |
SMARCC1 |
SMARCC1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis.
|
21552421 |
2011 |
|
| Entrez Id: |
1636 |
| Gene Symbol: |
ACE |
ACE
|
0.300 |
Biomarker
|
disease |
CTD_human |
Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis.
|
21552421 |
2011 |
|
| Entrez Id: |
6696 |
| Gene Symbol: |
SPP1 |
SPP1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis.
|
21552421 |
2011 |
|
| Entrez Id: |
1938 |
| Gene Symbol: |
EEF2 |
EEF2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Sumoylation of eukaryotic elongation factor 2 is vital for protein stability and anti-apoptotic activity in lung adenocarcinoma cells.
|
21554491 |
2011 |
|
| Entrez Id: |
780 |
| Gene Symbol: |
DDR1 |
DDR1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis.
|
21552421 |
2011 |
|
| Entrez Id: |
143187 |
| Gene Symbol: |
VTI1A |
VTI1A
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.
|
21892161 |
2011 |
|
| Entrez Id: |
348 |
| Gene Symbol: |
APOE |
APOE
|
0.300 |
Biomarker
|
disease |
CTD_human |
Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer.
|
20430468 |
2011 |
|
| Entrez Id: |
596 |
| Gene Symbol: |
BCL2 |
BCL2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma.
|
21472143 |
2011 |
|
| Entrez Id: |
4846 |
| Gene Symbol: |
NOS3 |
NOS3
|
0.300 |
Biomarker
|
disease |
CTD_human |
Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma.
|
21472143 |
2011 |
|
| Entrez Id: |
4233 |
| Gene Symbol: |
MET |
MET
|
0.300 |
Biomarker
|
disease |
CTD_human |
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib.
|
22042947 |
2011 |
|
| Entrez Id: |
1588 |
| Gene Symbol: |
CYP19A1 |
CYP19A1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma.
|
21472143 |
2011 |
|
| Entrez Id: |
2099 |
| Gene Symbol: |
ESR1 |
ESR1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Significance of estrogen receptor 1 (ESR-1) gene imbalances in colon and hepatocellular carcinomas based on tissue microarrays analysis.
|
20458558 |
2011 |
|
| Entrez Id: |
1490 |
| Gene Symbol: |
CCN2 |
CCN2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis.
|
21552421 |
2011 |
|
| Entrez Id: |
634 |
| Gene Symbol: |
CEACAM1 |
CEACAM1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis.
|
21552421 |
2011 |
|
| Entrez Id: |
2064 |
| Gene Symbol: |
ERBB2 |
ERBB2
|
0.300 |
Biomarker
|
disease |
CTD_human |
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib.
|
22042947 |
2011 |
|
TNFRSF10A
|
0.300 |
Biomarker
|
disease |
CTD_human |
Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma.
|
21472143 |
2011 |
|
| Entrez Id: |
2886 |
| Gene Symbol: |
GRB7 |
GRB7
|
0.300 |
Biomarker
|
disease |
CTD_human |
Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis.
|
21552421 |
2011 |
|
| Entrez Id: |
1028 |
| Gene Symbol: |
CDKN1C |
CDKN1C
|
0.300 |
Biomarker
|
disease |
CTD_human |
Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis.
|
21552421 |
2011 |
|
| Entrez Id: |
1956 |
| Gene Symbol: |
EGFR |
EGFR
|
0.300 |
Biomarker
|
disease |
CTD_human |
Intermittent chemotherapy and erlotinib for nonsmokers or light smokers with advanced adenocarcinoma of the lung: a phase II clinical trial.
|
21541241 |
2011 |
|
| Entrez Id: |
1956 |
| Gene Symbol: |
EGFR |
EGFR
|
0.300 |
Biomarker
|
disease |
CTD_human |
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib.
|
22042947 |
2011 |